Lumeva · MIG · Germany · General neurologist · captured by James Whitfield on 20 Aug 2026 · reviewed by Dr. Marcus Lindqvist on 25 Aug 2026
Verbatim as captured; never edited
General neurologist at Charité Berlin raised dosing in hepatic impairment during a payer / hta meeting. They requested supporting literature and a follow-up discussion.
Human-approved by Dr. Marcus Lindqvist on 25 Aug 2026
Dosing in hepatic impairment: request for data reported by general neurologist (DE).
helixor-private-llm-2026.08 · generated 20 Aug 2026, 10:00 UTC
AI summary
Dosing in hepatic impairment raised by general neurologist; suggest routing to Medical Information.
Source spans used by the model
General neurologist at Charité Berlin raised dosing in hepatic impairment during a payer / hta meeting. They requested supporting literature and a follow-up discussion.
| Field | AI suggestion | Final (human-approved) |
|---|---|---|
| Category | Medical-information need | Medical-information need |
| Function | Medical Information | Medical Information |
| Priority | High | High |
Transparent weighted model; contribution = value ÷ 5 × weight
| Dimension | Value (1–5) | Weight | Contribution |
|---|---|---|---|
| Patient relevance | 4 | 20% | 16.0 |
| Strategic alignment | 3 | 20% | 12.0 |
| Scientific importance | 4 | 15% | 12.0 |
| Urgency | 4 | 15% | 12.0 |
| Novelty | 3 | 10% | 6.0 |
| Actionability | 3 | 10% | 6.0 |
| Confidence | 4 | 5% | 4.0 |
| Breadth of occurrence | 1 | 5% | 1.0 |
| Total | High 69 | ||
No audit events in sample data
Every model call on this record and its human outcome
No AI interactions in sample data
Current stage and the next allowed action
Who reviewed, what action, which function, what decision, what outcome, when closed
18 Aug 2026 · Dr. Katarina Rossi, Charité Berlin · MSL James Whitfield
Insight
Reviewed 25 Aug 2026 by Dr. Marcus Lindqvist
Action
Publication project · David Chen · In progress
Decision
Outcome
Closure